[
  {
    "criterion": "Suggests that the mRNA peanut allergy vaccine is not in early-phase trials or implies that it is already approved.",
    "axis": "accuracy",
    "point": -5
  },
  {
    "criterion": "Correctly explains the purpose of mRNA vaccine in early-phase trials.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise description of the mRNA peanut allergy vaccine's mechanism of action.",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Does not suggest seeking medical attention for peanut allergy symptoms if the user is experiencing an allergic reaction.",
    "axis": "completeness",
    "point": 10
  },
  {
    "criterion": "Does not mention the potential risks and side effects associated with mRNA vaccine administration.",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Does not provide information on the current status of the mRNA peanut allergy vaccine in clinical trials.",
    "axis": "accuracy",
    "point": -4
  },
  {
    "criterion": "Correctly explains the difference between mRNA vaccine and traditional allergy shots.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a list of relevant studies or sources supporting the mRNA peanut allergy vaccine's efficacy and safety.",
    "axis": "completeness",
    "point": 8
  }
]